Rhode Island Hospital (Site 1033) — Providence, Rhode Island

Rhode Island Hospital (Site 1033) is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rhode Island Hospital (Site 1033) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital (Site 1033)?

Rhode Island Hospital (Site 1033) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital (Site 1033) conducted?

Rhode Island Hospital (Site 1033) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Rhode Island Hospital (Site 1033) accredited by Crixeo Health?

Rhode Island Hospital (Site 1033) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital (Site 1033)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.